Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Fresh Tracks Therapeutics Inc V.BBI


Primary Symbol: FRTX

Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.


PINL:FRTX - Post by User

Comment by EstevanOutsideron Oct 23, 2021 9:53am
187 Views
Post# 34040529

RE:RE:RE:$108 condensate

RE:RE:RE:$108 condensateThe volume has picked up substantially. Ninepoint has definetely been accumulating. This is a little known name. I think Ninepoint might own at least 8-10,000,000 shares right now. If Riverstone or GMT are smart, they'll sell Ninepoint a large block so he can promote the name to retail buyers. As Pipestone said on the Peters & Co call, they cater to retail investors because their tightly held float. But I think the distributed of shares from CNOR (Riverstone) into smaller groups may be to enable the buyback easier???

Just my thoughts. If drilling execution goes as planned, Pipestone will look totally different next year and I doubt volume won't improve. We're just emerging from a bear market afterall...


navajojoe wrote:
EstevanOutsider wrote: An ncib in Q4 could be a pretty bug catalyst. I have a big position here. Probably will for all of 2022. An easy triple if commodity prices hold.


Considering the low trading volume, any buying by the company would certainly compete heavily with market participants.
Maybe a combination of buying back shares and continuing to masscare the debt would be a great one-two punch?


<< Previous
Bullboard Posts
Next >>